Supplements

Diabetes and obesity: Managing dual epidemics


 

Supplement Editor:
M. Cecilia Lansang, MD, MPH

Contents

Diabetes and obesity: Managing dual epidemics
M. Cecilia Lansang, MD, MPH

Diabetes with obesity—Is there an ideal diet?
Zahrae Sandouk and M. Cecilia Lansang

The essential role of exercise in the management of type 2 diabetes
John P. Kirwan, Jessica Sacks, and Stephan Nieuwoudt

Optimizing diabetes treatment in the presence of obesity
Mary Angelynne Esquivel and M. Cecilia Lansang

Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?
Bartolome Burguera, Khawla F. Ali, and Juan P. Brito

Metabolic surgery for treating type 2 diabetes mellitus: Now supported by the world's leading diabetes organizations
Philip R. Schauer, Zubaidah Nor Hanipah, and Francesco Rubino

— Bonus Article —Medical Treatment of Diabetes Mellitus
Mario Skugor

Recommended Reading

Consistent weight benefits seen in empagliflozin use
Type 2 Diabetes ICYMI
IDegLira equals basal-bolus insulin in HbA1c, lowers hypoglycemia risk
Type 2 Diabetes ICYMI
Telemedicine Boosts Number of Native Americans Who Can Obtain Retina Exams
Type 2 Diabetes ICYMI
ODYSSEY: Alirocumab improves lipids but not glycemic targets in 2DM
Type 2 Diabetes ICYMI
DURATION-8: Exenatide/dapagliflozin efficacy holds up at 1 year
Type 2 Diabetes ICYMI
SPRINT: Intensive BP control cut cardiovascular risk in patients with prediabetes
Type 2 Diabetes ICYMI
FDA advisory committee supports new CV liraglutide indication
Type 2 Diabetes ICYMI
Oral insulin matches glargine in phase II trial
Type 2 Diabetes ICYMI
Nocturia and sleep apnea
Type 2 Diabetes ICYMI
Effect of Non–Insulin-Based Glucose-Lowering Therapies on Cardiovascular Outcomes in Patients With Type 2 Diabetes
Type 2 Diabetes ICYMI